167
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Elevated endocan concentration is associated with coronary slow flow

, , , &
Pages 345-348 | Received 20 Aug 2015, Accepted 10 Apr 2016, Published online: 16 May 2016

References

  • Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon-a new coronary microvascular disorder. Cardiology 2002;97:197–202.
  • Horjeti B, Goda A. Acute ischemia manifestation in a patient with coronary slow flow phenomenon. J Electrocardiol 2012;45:277–9.
  • Acikel S, Bozkaya OA, Akdemir R. The relationship between intermittent left bundle-branch block and slow coronary flow in a patient presenting with acute coronary syndrome. Blood Coagul Fibrinolysis 2010;21:595–7.
  • Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, Yetkin E, Tandogan I, Kosar F, Ermis N, Yologlu S, Bariskaner E, Cehreli S. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003;14:155–61.
  • Enli Y, Turk M, Akbay R, Evrengul H, Tanriverdi H, Kuru O, Seleci D, Kaftan A, Ozer O, Enli H. Oxidative stress parameters in patients with slow coronary flow. Adv Ther 2008;25:37–44.
  • Xu Y, Meng HL, Su YM, Chen C, Huang YH, Li XF, Fan MK, Yan YJ, Wu J, Jiang MH, Pan M. Serum YKL-40 is increased in patients with slow coronary flow. Coron Artery Dis 2015;26:121–5.
  • Simsek H, Sahin M, Gunes Y, Akdag S, Akil MA, Akyol A, Gumrukcuoglu HA, Yaman M. A novel echocardiographic method as an indicator of endothelial dysfunction in patients with coronary slow flow. Eur Rev Med Pharmacol Sci 2013;17:689–93.
  • Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996;271:20458–64.
  • Aparci M, Isilak Z, Uz O, Yalcin M, Kucuk U. Endocan and endothelial dysfunction. Angiology 2015;66:488–9.
  • Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, Wei W, Wang Y. Expression and distribution of endocan in human tissues. Biotech Histochem 2012;87:172–8.
  • Gibson CM, Cannon CP, Daley WL, Dodge JT, Jr., Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879–88.
  • Selcuk MT, Selcuk H, Temizhan A, Maden O, Ulupinar H, Baysal E, Ozeke O, Sasmaz A. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow. Coron Artery Dis 2007;18:545–51.
  • Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, Zhang CY, Li J. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 2007;385:43–7.
  • Akpinar I, Sayin MR, Gursoy YC, Aktop Z, Karabag T, Kucuk E, Sen N, Aydin M, Kiran S, Buyukuysal MC, Haznedaroglu IC. Plateletcrit and red cell distribution width are independent predictors of the slow coronary flow phenomenon. J Cardiol 2014;63:112–18.
  • Cin VG, Pekdemir H, Camsar A, Ciçek D, Akkus MN, Parmaksýz T, Katýrcýbaý T, Döven O. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J 2003;44:907–19.
  • Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M, Celik T, Turker T, Iyisoy A. Endocan–a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology 2014;65:773–7.
  • Wang XS, Yang W, Luo T, Wang JM, Jing YY. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension. Genet Test Mol Biomarkers 2015;19:124–7.
  • Altintas N, Mutlu LC, Akkoyun DC, Aydin M, Bilir B, Yilmaz A, Malhotra A. Effect of CPAP on new endothelial dysfunction marker, endocan, in people with obstructive sleep apnea. Angiology 2016;67:364–74.
  • Yang J, Yang Q, Yu S, Zhang X. Endocan: a new marker for cancer and a target for cancer therapy. Biomed Rep 2015;3:279–83.
  • Kirkpatrick CJ, Wagner M, Hermanns I, Klein CL, Köhler H, Otto M, van Kooten TG, Bittinger F. Physiology and cell biology of the endothelium: a dynamic interface for cell communication. Int J Microcirc Clin Exp 1997;17:231–40.
  • Panés J, Perry M, Granger DN. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol 1999;126:537–50.
  • Lee W, Ku SK, Kim SW, Bae JS. Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol 2014;229:620–30.
  • Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 2014;63:1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.